Hindilerden, F. Et Al. 2022. Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen. Hematology Reports , vol.14, no.3 , 222-227.

Hindilerden, F., Yonal-Hindilerden, I., Yenerel, M. N., Nalcaci, M., & Diz-Kucukkaya, R., (2022). Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen. Hematology Reports , vol.14, no.3, 222-227.

Hindilerden, Fehmi Et Al. "Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen," Hematology Reports , vol.14, no.3, 222-227, 2022

Hindilerden, Fehmi Et Al. "Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen." Hematology Reports , vol.14, no.3, pp.222-227, 2022

Hindilerden, F. Et Al. (2022) . "Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen." Hematology Reports , vol.14, no.3, pp.222-227.

@article{article, author={Fehmi Hindilerden Et Al. }, title={Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen}, journal={Hematology Reports}, year=2022, pages={222-227} }